Integra LifeSciences Holdings Corporation
IART
$15.10
-$0.02-0.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.85% | -3.59% | -3.50% | -14.59% | -59.65% |
| Total Receivables | 4.74% | 2.38% | 2.36% | 2.42% | 1.56% |
| Inventory | 11.14% | 14.83% | 11.94% | 10.28% | 10.41% |
| Prepaid Expenses | -5.93% | 24.79% | 9.02% | 10.49% | 42.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.21% | -5.14% | -28.72% | 62.95% | 135.09% |
| Total Current Assets | 5.85% | 7.20% | 4.01% | 2.75% | -21.79% |
|
|
|||||
| Total Current Assets | 5.85% | 7.20% | 4.01% | 2.75% | -21.79% |
| Net Property, Plant & Equipment | 4.04% | 6.39% | 7.13% | 9.66% | 12.91% |
| Long-term Investments | -44.52% | -43.92% | -44.90% | -44.20% | 6.26% |
| Goodwill | -44.52% | -43.92% | -44.90% | -44.20% | 6.26% |
| Total Other Intangibles | -6.92% | -6.04% | -4.08% | -2.61% | 16.13% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.41% | 50.45% | 78.37% | 78.68% | 4.44% |
| Total Assets | -11.72% | -10.78% | -10.31% | -9.98% | -0.62% |
|
|
|||||
| Total Accounts Payable | -3.67% | 16.03% | 18.85% | -13.64% | -3.29% |
| Total Accrued Expenses | -3.18% | -3.09% | 12.34% | 5.72% | 51.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -91.44% | -91.34% | -91.29% | 1,493.98% | 1,633.27% |
| Total Finance Division Other Current Liabilities | 99.40% | 13.66% | -55.04% | 163.73% | -75.35% |
| Total Other Current Liabilities | 99.40% | 13.66% | -55.04% | 163.73% | -75.35% |
| Total Current Liabilities | -62.24% | -50.55% | -60.11% | 183.20% | 203.73% |
|
|
|||||
| Total Current Liabilities | -62.24% | -50.55% | -60.11% | 183.20% | 203.73% |
| Long-Term Debt | 48.35% | 44.52% | 48.58% | -31.88% | -33.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.84% | -2.32% | -4.10% | -6.07% | -5.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.27% | 1.69% | 13.13% | 30.17% | 28.01% |
| Total Liabilities | 0.27% | 2.66% | 2.54% | 3.50% | 1.95% |
|
|
|||||
| Common Stock & APIC | 1.33% | 1.13% | 1.26% | 2.04% | 0.96% |
| Retained Earnings | -54.21% | -54.95% | -53.81% | -53.76% | -3.07% |
| Treasury Stock & Other | -0.50% | -0.04% | -0.74% | -3.07% | -8.74% |
| Total Common Equity | -31.61% | -32.47% | -31.81% | -32.30% | -4.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -31.61% | -32.47% | -31.81% | -32.30% | -4.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -31.61% | -32.47% | -31.81% | -32.30% | -4.62% |
|
|
|||||